Monopar Therapeutics

Home » Monopar Therapeutics

IPO

Monopar Therapeutics

Biopharmaceutical

We are a clinical stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients.

Symbol

MNPR

Price Range
$8.00 - $10.00

Final Shares
2,222,223

Anticipated Date
November 8, 2019

Underwriters
JONESTRADING

To view the prospectus for Monopar Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253